secwatch / observer
8-K filed May 10, 2023, 7:59 PM ET ticker AVD CIK 0000005981
earnings confidence high sentiment negative materiality 0.75

AVD Q1 net sales down 17%, EPS $0.07 vs $0.33 YoY; credit covenant amended

AMERICAN VANGUARD CORP

2023-Q1 EPS reported $0.07 revenue$124,885,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMERICAN VANGUARD CORP reported full year 2023 results: revenue $ 640MM - $652MM, net income $ 32MM - $34MM. Guidance reaffirmed.

Period
full year 2023
Revenue
$ 640MM - $652MM
Net income
$ 32MM - $34MM
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
2023 Performance Targets Metric 2023 Range 2022 Actual % Change Net sales $ 640MM - $652MM $ 610MM 5 to 7 % Gross margin % 33 to 35 % 34 % Similar Opex as % of sales 25 to 27 % 25 % Similar Adjusted EBITDA $ 84MM - $86MM $ 73MM 14 to 18 % Net income $ 32MM - $34MM $ 27.5MM 17 to 25 %
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMERICAN VANGUARD CORP reported the quarter ended March 31, 2023 results: revenue $ 124,885, net income $ 1,918, EPS $ 0.07.

Period
the quarter ended March 31, 2023
Revenue
$ 124,885
Net income
$ 1,918
EPS
$ 0.07
Result
reported results
Exact text from the filing
decrease in sales of higher-margin US crop products led to lower overall profitability.” In thousands except for per share data March 31, 2023 March 31, 2022 Change Net sales $ 124,885 $ 149,593 $ (24,708 ) Net income $ 1,918 $ 9,935 $ (8,017 ) EPS $ 0.07 $ 0.33 $ (0.26 ) Adjusted EBITDA 1 $ 11,511 $ 22,867 $ (11,356 ) Mr. Wintemute continued, “Even after taking
View on SEC.gov

Browse all earnings releases →

AMERICAN VANGUARD CORP filing history →

Source: SEC EDGAR
accession 0001193125-23-140690
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.